F Van den Akker - JoVE Visualize

Showing results (11-20 of 24) with videos related to

Pageof 3

Sort By:

Current Genomics|June 19, 2015

Heart Failure in Chronic Myocarditis: A Role for microRNAs?P van den Hoogen, F van den Akker, J C Deddens, et al.

Biochemistry|September 5, 1995

The Arg7Lys mutant of heat-labile enterotoxin exhibits great flexibility of active site loop 47-56 of the A subunitF van den Akker, E A Merritt, M Pizza, et al.

Nature|July 14, 2000

Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptorF van den Akker, X Zhang, M Miyagi, et al.

Protein Science : a Publication of the Protein Society|February 1, 1994

Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharideE A Merritt, S Sarfaty, F van den Akker, et al.

Antimicrobial Agents and Chemotherapy|September 26, 2023

Exploring avibactam and relebactam inhibition of <i>Klebsiella pneumoniae</i> carbapenemase D179N variant: role of the Ω loop-held deacylation waterT A Alsenani, S L Viviani, K M Papp-Wallace, et al.

Protein Science : a Publication of the Protein Society|January 7, 1998

Crystal structure of heat-labile enterotoxin from Escherichia coli with increased thermostability introduced by an engineered disulfide bond in the A subunitF van den Akker, I K Feil, C Roach, et al.

Structure (London, England : 1993)|June 15, 1996

Crystal structure of a new heat-labile enterotoxin, LT-IIbF van den Akker, S Sarfaty, E M Twiddy, et al.

Molecular Microbiology|May 1, 1996

Protein engineering studies of A-chain loop 47-56 of Escherichia coli heat-labile enterotoxin point to a prominent role of this loop for cytotoxicityI K Feil, R Reddy, L de Haan, et al.

Protein Engineering|January 7, 1999

Stepwise transplantation of an active site loop between heat-labile enterotoxins LT-II and LT-I and characterization of the obtained hybrid toxinsI K Feil, A A Platas, F van den Akker, et al.

Panminerva Medica|March 16, 2010

Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic resultsW A Noort, D Feye, F Van Den Akker, et al.

Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:

Pageof 3

Current Genomics|June 19, 2015

Heart Failure in Chronic Myocarditis: A Role for microRNAs?P van den Hoogen, F van den Akker, J C Deddens, et al.

Biochemistry|September 5, 1995

The Arg7Lys mutant of heat-labile enterotoxin exhibits great flexibility of active site loop 47-56 of the A subunitF van den Akker, E A Merritt, M Pizza, et al.

Nature|July 14, 2000

Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptorF van den Akker, X Zhang, M Miyagi, et al.

Protein Science : a Publication of the Protein Society|February 1, 1994

Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharideE A Merritt, S Sarfaty, F van den Akker, et al.

Antimicrobial Agents and Chemotherapy|September 26, 2023

Exploring avibactam and relebactam inhibition of <i>Klebsiella pneumoniae</i> carbapenemase D179N variant: role of the Ω loop-held deacylation waterT A Alsenani, S L Viviani, K M Papp-Wallace, et al.

Protein Science : a Publication of the Protein Society|January 7, 1998

Crystal structure of heat-labile enterotoxin from Escherichia coli with increased thermostability introduced by an engineered disulfide bond in the A subunitF van den Akker, I K Feil, C Roach, et al.

Structure (London, England : 1993)|June 15, 1996

Crystal structure of a new heat-labile enterotoxin, LT-IIbF van den Akker, S Sarfaty, E M Twiddy, et al.

Molecular Microbiology|May 1, 1996

Protein engineering studies of A-chain loop 47-56 of Escherichia coli heat-labile enterotoxin point to a prominent role of this loop for cytotoxicityI K Feil, R Reddy, L de Haan, et al.

Protein Engineering|January 7, 1999

Stepwise transplantation of an active site loop between heat-labile enterotoxins LT-II and LT-I and characterization of the obtained hybrid toxinsI K Feil, A A Platas, F van den Akker, et al.

Panminerva Medica|March 16, 2010

Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic resultsW A Noort, D Feye, F Van Den Akker, et al.

Pageof 3